JAPAN AS REPRESENTED BY PRESIDENT OF NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY MINISTRY OF HEALT
发明人:
ANNOURA, HIROKAZU,MURATA, KENJI,YAMAMURA, TAKASHI
申请号：
ES04710993
公开号：
ES2450043T3
申请日:
2004.02.13
申请国别(地区):
ES
年份:
2014
代理人:
摘要：
A compound that is a glycolipid having the formula (I): ** Formula ** wherein R3 indicates a substituted or unsubstituted cycloalkyl group, substituted or unsubstituted aryl group, or substituted or unsubstituted aralkyl group, and R8 indicates - ( CH2) m-CH3 where m is from 10 to 25, C6 to C35 aryl group unsubstituted or substituted with an alkyl group, alkoxy group or amide group, or C7 to C35 aralkyl group unsubstituted or substituted with an alkyl group, alkoxy group ogroup amide； or a hydrate of these.Un compuesto que es un glicolípido que tiene la fórmula (I):**Fórmula** en donde R3 indica un grupo cicloalquilo sustituido o no sustituido, grupo arilo sustituido o no sustituido, o grupo aralquilosustituido o no sustituido, y R8 indica -(CH2)m-CH3 dónde m es de 10 a 25, grupo arilo C6 a C35 no sustituido o sustituido con un grupo alquilo,grupo alcoxi o grupo amida, o grupo aralquilo C7 a C35 no sustituido o sustituido con un grupo alquilo, grupo alcoxi ogrupo amida； o un hidrato de estos.
